Augustine O. Olusola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Augustine O. Olusola has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Babatunji Emmanuel Oyinloye
Biotechnology and Structural Biology (BSB) Group, Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa; Institute of Drug Research and Development, SE Bogoro Center, Afe Babalola University, PMB 5454, Ado, Ekiti 360001, Nigeria
1 shared publication- Bashir Lawal
UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA
1 shared publication - Chih-Hao Wang
Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 406040, Taiwan
1 shared publication Gaber El-Saber Batiha
Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt
1 shared publicationGomaa Mostafa-Hedeab
Pharmacology Department & Health Research Unit, Medical College, Jouf University, Jouf, Saudi Arabia; Pharmacology Department, Faculty of Medicine, Beni-Suef University, Egypt
1 shared publicationMohammed Alorabi
Department of Biotechnology, College of Sciences, Taif University, P.O.Box 11099, Taif 21944, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 17 February 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 148, 112730
Therapeutic efficacy of Clompanus pubescens leaves fractions via downregulation of neuronal cholinesterases/Na+-K+ATPase/IL-1 β, and improving the neurocognitive and antioxidants status of streptozotocin-induced diabetic rats
- 17 February 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 148, 112730
Open AccessTherapeutic efficacy of Clompanus pubescens leaves fractions via downregulation of neuronal cholinesterases/Na+-K+ATPase/IL-1 β, and improving the neurocognitive and antioxidants status of streptozotocin-induced diabetic rats